The last word to new FDA draft guidance for cancer clinical trial eligibility criteria for patients with incurable cancer

被引：0
|
作者：
Lythgoe, Mark P. [1 ]
Prasad, Vinay [2 ]
机构：
[1] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, Du Cane Rd, London W12 0HS, England
[2] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
JOURNAL OF CANCER POLICY | 2022年 / 31卷
关键词：
D O I：
10.1016/j.jcpo.2022.100322
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
    Tan, Aaron C.
    Boggs, Drexell H.
    Lee, Eudocia Q.
    Kim, Michelle M.
    Mehta, Minesh P.
    Khasraw, Mustafa
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [2] Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access
    Oluloro, Ann
    Swisher, Elizabeth M.
    Gray, Heidi J.
    Goff, Barbara
    Doll, Kemi M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [3] Clinical Significance of Eligibility Criteria Determined by the SPIRITS Trial in Patients with Advanced Gastric Cancer
    Satake, Souichi
    Arigami, Takaaki
    Matsushita, Daisuke
    Okubo, Keishi
    Shimonosono, Masataka
    Sasaki, Ken
    Tsuruda, Yusuke
    Tanabe, Kan
    Mori, Shinichiro
    Yanagita, Shigehiro
    Uenosono, Yoshikazu
    Nakajo, Akihiro
    Kurahara, Hiroshi
    Ohtsuka, Takao
    ONCOLOGY, 2023, 101 (01) : 12 - 21
  • [4] New Cancer Clinical Trial Guidance
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (13): : 1219 - 1219
  • [5] MAPPING REAL-WORD PSORIATIC ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Arendse, Regan
    Haaland, Derek
    Fortin, Isabelle
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen J.
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 10 - 10
  • [6] MAPPING REAL-WORD ANKYLOSING SPONDYLITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen J.
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 9 - 10
  • [7] MAPPING REAL-WORD RHEUMATOID ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Keystone, Ed
    Olsynski, Wojciech
    Bessette, Louis
    Rahman, Proton
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Asin-Milan, Odalis
    Nantel, Francois
    Rachich, Meagan
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 10 - 10
  • [8] FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
    Russell, Elizabeth S.
    Aubrun, Elodie
    Moga, Daniela C.
    Guedes, Sandra
    Camelo Castillo, Wendy
    Hardy, Janet R.
    Cole, J. Alexander
    Jagun, Oladayo
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [9] The best management for most patients with incurable cancer is on a clinical trial
    Subbiah, V.
    Kurzrock, R.
    ANNALS OF ONCOLOGY, 2025, 36 (03) : 240 - 243
  • [10] Outcomes of cancer patients who do not satisfy conventional clinical trial eligibility criteria (CTEC)
    Cheung, Winson Y.
    Javaheri, Khodadad Rasool
    Speers, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
12345